Mainstay malaria drug may be beginning to fail in the Horn of Africa

In eastern Africa, malaria parasites have developed resistance to artemisinins, the backbone of current treatment regimens, a development that could dramatically worsen malaria’s impact if partner drugs fail in the future.

Leave A Comment

Your email address will not be published. Required fields are marked *